Editas Medicine Inc EDIT shares are trading higher by $2.00 (9 percent) at $26.30 in Thursday's session.
The issue is following through on its $5.44 gain from Wednesday's session. That rally was instigated by an announcement confirming a US Patent And Trademark Office decision favorable to Broad Institute in CRISPR Interference.
After a flat open, Editas declined to $23.50 before embarking on its move higher. So far, the ensuing rally has taken the issue to $26.47 and isn't far off that level. That marks the highest level for the issue since it peaked on July 29 at $27.57.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.